Yield10 Bioscience, Inc. Common Stock
YTEN
YTEN was delisted on the 15th of May, 2024.
10 hedge funds and large institutions have $1.74M invested in Yield10 Bioscience, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, reducing their positions, and 3 closing their positions.
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
43% more funds holding
Funds holding: 7 → 10 (+3)
6% more capital invested
Capital invested by funds: $1.64M → $1.74M (+$104K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$457K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$117K |
| 3 |
GC
GMT Capital
Atlanta,
Georgia
|
+$59.3K |
| 4 |
Jane Street
New York
|
+$35.6K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$28.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$381K |
| 2 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$277K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$123K |
YTEN Hedge Fund Activity: Q1 2018 in Review
10 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q1 2018, worth a combined $1.74M — up 6.3% from $1.64M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new YTEN positions and 3 closed out — a net gain of 3 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $457K. The largest seller was Sabby Management, exiting entirely with an estimated $381K sold.
- 10 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q1 2018, up from 7 in Q4 2017.
- Funds reported $1.74M of Yield10 Bioscience, Inc. Common Stock stock for Q1 2018, up 6.3% quarter-over-quarter.
- 6 funds opened new Yield10 Bioscience, Inc. Common Stock positions in Q1 2018 and 3 closed out, a net change of +3 holders.
- The largest Yield10 Bioscience, Inc. Common Stock buyer in Q1 2018 was Renaissance Technologies, an estimated $457K added.
- The largest Yield10 Bioscience, Inc. Common Stock seller in Q1 2018 was Sabby Management, an estimated $381K sold.
Based on aggregated 13F filings for Q1 2018.